Source / episode info

• **Episode:**72
• **Title:**Divine Intervention Episode 72 – Endocrine Physiology and Pharmacology Part 1
• **Published:**2019-01-11
• Source:Episode page

One-liner

This episode provides an integrated review of calcium and phosphate homeostasis (PTH axis), thyroid hormone synthesis/pharmacology (PTU vs Methimazole), diabetes management (insulin types, metformin mechanism), and the clinical presentation of endocrine tumors like MEN syndromes.

High-yield summary

• Calcium Homeostasis: PTH raises blood calcium by increasing renal reabsorption in the DCT, inhibiting phosphate reabsorption in the PCT, activating 1-hydroxylase to produce active Vitamin D (Calcitriol), and stimulating osteoclast activity via RANKL/RANK.
• Hypercalcemia Workup Differentiation: Primary hyperparathyroidism (PHPT) has high urinary calcium; Familial Hypocalciuric Hypercalcemia (FHH) has low urinary calcium due to a defective Calcium Sensing Receptor (CaSR).
• Thyroid Storm Management: The initial, critical step is administering a beta-blocker (Propranolol) regardless of the drug used. Subsequent treatments include antithyroid drugs (PTU/Methimazole), iodine load ({KI}), and steroids.
• Metformin Mechanism: Metformin improves insulin sensitivity by activating AMP kinase, which promotes the translocation of GLUT4 transporters to the cell surface in an insulin-independent manner, particularly during exercise.
• MEN Syndromes: MEN2A involves Medullary Thyroid Cancer (Calcitonin marker) and Pheochromocytoma originating in the posterior mediastinum; prophylactic total thyroidectomy is recommended for both MEN2A and MEN2B due to high risk of MTC.

Learning objectives

• Differentiate the physiological and biochemical findings in primary vs. secondary hyperparathyroidism.
• Describe the mechanism of action for key anti-thyroid drugs (PTU, Methimazole) and their appropriate use in thyroid storm.
• Explain how metformin improves insulin sensitivity via AMP kinase activation and GLUT4 translocation.
• Identify the characteristic laboratory pattern distinguishing PHPT from FHH using urinary calcium excretion.
• Recognize the clinical manifestations and associated tumor markers for MEN syndromes (e.g., Calcitonin in MTC, PTHrP in lung cancer).

Board exam buzzwords